Follow
Minh N. Tran
Minh N. Tran
PhD student, Semmelweis University
Verified email at ump.edu.vn
Title
Cited by
Cited by
Year
Streptococcus suis Meningitis in Adults in Vietnam
N Thi Hoang Mai, N Thi Hoa, T Vu Thieu Nga, L Dieu Linh, ...
Clinical Infectious Diseases 46 (5), 659-667, 2008
3792008
Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
MN Tran, T Medveczki, B Besztercei, G Torok, AJ Szabo, X Gasull, ...
Life 13 (7), 1581, 2023
22023
Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
J Hodrea, MN Tran, B Besztercei, T Medveczki, AJ Szabo, L Orfi, I Kovacs, ...
International Journal of Molecular Sciences 24 (14), 11646, 2023
12023
Fluvoxamine supresses transforming growth factor beta‐2‐induced fibrotic changes in trabecular meshwork cells
T Medveczki, MN Tran, B Besztercei, G Torok, I Kovacs, AJ Szabo, ...
Acta Ophthalmologica 102, 2024
2024
Sigma-1 receptor agonist ameliorates trabecular meshwork fibrosis by modulating extracellular matrix remodeling and increasing nitric oxide production
J Hodrea, MN Tran, B Besztercei, T Medveczki, I Kovacs, X Gasull, ...
Investigative Ophthalmology & Visual Science 64 (8), 3450-3450, 2023
2023
Sigma − 1 receptor activation as a new option for the treatment of glaucoma in preclinical models
JH Andrea Fekete, Minh N. Tran, Balazs Besztercei, Gyorgy Torok, Timea ...
Acta Ophthalmologica 100 (S275), 2022
2022
The Protective Role of the Sigma-1 Receptor in Trabecular Meshwork Cells in vitro
J Hodrea, M Tran, B Besztercei, I Kovacs, X Gasull, A Szabo, A Fekete
Investigative Ophthalmology & Visual Science 63 (7), 2858–A0381-2858–A0381, 2022
2022
The Sigma-1 Receptor Agonist Fluvoxamine prevents Dexamethasone-induced Ocular Hypertension in vivo.
I Kovacs, M Tran, J Hodrea, G Török, Á Tóth, T Lakat, A Szabo, A Fekete
Investigative Ophthalmology & Visual Science 63 (7), 2841–A0364-2841–A0364, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8